Assessment of Metabolic Phenotypes in Patients with Non-ischemic Dilated Cardiomyopathy Undergoing Cardiac Resynchronization Therapy
暂无分享,去创建一个
Neema Jamshidi | Sebastian Obrzut | N. Jamshidi | C. Hoh | U. Birgersdotter-Green | S. Obrzut | Carl Hoh | Ulrika Birgersdotter-Green | Jay Tiongson | Huy Minh Phan | H. Phan | J. Tiongson
[1] O. Mjøs. Effect of free fatty acids on myocardial function and oxygen consumption in intact dogs. , 1971, The Journal of clinical investigation.
[2] J. Lammerant,et al. Inhibitory effects of the D(-)isomer of 3-hydroxybutyrate on cardiac non-esterified fatty acid uptake and oxygen demand induced by norepinephrine in the intact dog. , 1985, Journal of molecular and cellular cardiology.
[3] J. Schroeder,et al. Effects of Cardiac Resynchronization on Disease Progression in Patients With Left Ventricular Systolic Dysfunction, an Indication for an Implantable Cardioverter-Defibrillator, and Mildly Symptomatic Chronic Heart Failure , 2004, Circulation.
[4] D. Kelly,et al. Fatty acid oxidation enzyme gene expression is downregulated in the failing heart. , 1996, Circulation.
[5] H. Yki-Järvinen,et al. Free fatty acid kinetics and oxidation in congestive heart failure. , 1998, The American journal of cardiology.
[6] J. Kjekshus,et al. Effect of free fatty acids on myocardial function and metabolism in the ischemic dog heart. , 1972, The Journal of clinical investigation.
[7] Bristow. Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) : Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure , 2004 .
[8] T. Myrmel,et al. Myocardial substrate metabolism influences left ventricular energetics in vivo. , 2000, American journal of physiology. Heart and circulatory physiology.
[9] B O Palsson,et al. Flux-balance analysis of mitochondrial energy metabolism: consequences of systemic stoichiometric constraints. , 2001, American journal of physiology. Regulatory, integrative and comparative physiology.
[10] Jeroen J. Bax,et al. Imaging cardiac resynchronization therapy. , 2009, JACC. Cardiovascular imaging.
[11] C. Dence,et al. Impact of aging on substrate metabolism by the human heart. , 2003, Journal of the American College of Cardiology.
[12] P. Tchou,et al. Cardiac-resynchronization therapy in heart failure with narrow QRS complexes. , 2007, The New England journal of medicine.
[13] L. Jorfeldt,et al. Myocardial metabolism before and after valve replacement for aortic stenosis. , 2006, The Journal of cardiovascular surgery.
[14] Harvey J. Greenberg,et al. Reconstruction and Functional Characterization of the Human Mitochondrial Metabolic Network Based on Proteomic and Biochemical Data* , 2004, Journal of Biological Chemistry.
[15] D. DeMets,et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. , 2004, The New England journal of medicine.
[16] D. Burkhoff,et al. Influence of metabolic substrate on rat heart function and metabolism at different coronary flows. , 1991, The American journal of physiology.
[17] T. DeGrado,et al. Myocardial Free Fatty Acid and Glucose Use After Carvedilol Treatment in Patients With Congestive Heart Failure , 2001, Circulation.
[18] C. Metz,et al. Maximum likelihood estimation of receiver operating characteristic (ROC) curves from continuously-distributed data. , 1998, Statistics in medicine.
[19] K. Ellenbogen,et al. Resynchronization Therapy for the Treatment of Heart Failure , 2003, Circulation.
[20] J. Kjekshus,et al. Importance of free fatty acids as a determinant of myocardial oxygen consumption and myocardial ischemic injury during norepinephrine infusion in dogs. , 1974, The Journal of clinical investigation.
[21] A. Liedtke,et al. Fatty acid kinetics in aerobic myocardium: characteristics of tracer carbon entry and washout and influence of metabolic demand. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[22] J. Kjekshus,et al. Increased local metabolic rate by free fatty acids in the intact dog heart. , 1971, Scandinavian journal of clinical and laboratory investigation.
[23] M. Mayr,et al. Myocardial metabolism of free fatty acids. Studies with 14C-labeled substrates in humans. , 1987, The Journal of clinical investigation.
[24] G. Paolisso,et al. Total-body and myocardial substrate oxidation in congestive heart failure. , 1994, Metabolism: clinical and experimental.
[25] M. Chandler,et al. Short-Term Treatment With Ranolazine Improves Mechanical Efficiency in Dogs With Chronic Heart Failure , 2002, Circulation research.
[26] R. Lerch,et al. Postinfarction heart failure in rats is associated with upregulation of GLUT-1 and downregulation of genes of fatty acid metabolism. , 2001, Cardiovascular research.
[27] J. Daubert,et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. , 2005, The New England journal of medicine.
[28] D. Kelly,et al. Fatty acid utilization in the hypertrophied and failing heart: molecular regulatory mechanisms. , 1999, The American journal of the medical sciences.
[29] J. Kjekshus,et al. The Effect of Free Fatty Acids on Myocardial Oxygen Consumption During Atrial Pacing and Catecholamine Infusion in Man , 1978, Circulation.
[30] M. Chandler,et al. Ranolazine, a partial fatty acid oxidation (pFOX) inhibitor, improves left ventricular function in dogs with chronic heart failure. , 2002, Journal of cardiac failure.
[31] Sang Yup Lee,et al. MetaFluxNet: the management of metabolic reaction information and quantitative metabolic flux analysis , 2003, Bioinform..
[32] Jeroen J. Bax,et al. Results of the Predictors of Response to CRT (PROSPECT) Trial , 2008, Circulation.
[33] P Stanko,et al. An evaluation of myocardial fatty acid and glucose uptake using PET with [18F]fluoro-6-thia-heptadecanoic acid and [18F]FDG in Patients with Congestive Heart Failure. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[34] William C Stanley,et al. Myocardial substrate metabolism in the normal and failing heart. , 2005, Physiological reviews.
[35] D. Delurgio,et al. Effect of Cardiac Resynchronization Therapy on Left Ventricular Size and Function in Chronic Heart Failure , 2003, Circulation.
[36] P. Herrero,et al. Altered myocardial fatty acid and glucose metabolism in idiopathic dilated cardiomyopathy. , 2002, Journal of the American College of Cardiology.
[37] P. Bridge,et al. Increasing physicians' awareness of the impact of statistics on research outcomes: comparative power of the t-test and and Wilcoxon Rank-Sum test in small samples applied research. , 1999, Journal of clinical epidemiology.